Feasibility of evaluating the effectiveness of an interprofessional rehabilitation program for people with chronic low back pain in Ethiopia: a pilot randomized control trial protocol Authors: Sintayehu Daba Wami, Catherine Donnelly, Kassahun Alemu, Esayas Adefris, Jordan Miller Published: 2026 ABSTRACT AbstractBackgroundChronic low back pain (CLBP) is a significant public health problem and the leading cause of years lived with disability globally. Evidence suggests that interprofessional rehabilitation programs are effective for people with CLBP in improving health-related quality of life, reducing pain, and improving function and work abilities for people with CLBP. So far, however, little attention has been given to interprofessional rehabilitation programs for people with CLBP in low- and middle-income countries. Hence, this pilot randomized control trial (RCT) aims to evaluate the feasibility of conducting a future fully powered RCT to assess the effectiveness of an interprofessional rehabilitation program compared to the usual care for people with CLBP in Ethiopia.MethodsA two-arm parallel pilot RCT, with embedded mixed methods process evaluation, will be employed. A total of 40 patients with CLBP will be randomly assigned to the intervention and control groups at a 1:1 ratio. Participants of the intervention group will receive interprofessional rehabilitation that contains progressive physical activity and exercise, pain education, psychological interventions, and task-oriented and ergonomic interventions components. The comparison group participants will receive usual care for the same 4-week period. The primary outcome will be the feasibility of trial procedures (recruitment rate, retention rate, adherence rate, and acceptability of intervention). Secondary outcomes include the outcomes planned for the full trial, including physical functioning, pain intensity, pain self-efficacy, and health-related quality of life. Results will be analyzed and reported using descriptive statistics. The process evaluation will include a fidelity checklist, adherence measures, and qualitative interviews with 10 patients and all care providers involved to understand their experiences, barriers, and facilitators to implementing the intervention and trial methods with the goal of refining the intervention and trial methods in preparation for the fully powered trial.DiscussionThis pilot RCT will be critical to informing the methods, minimizing uncertainties, and increasing the likelihood of successfully conducting a definitive RCT in the future. In addition, it provides a source of evidence for other initiatives aimed at developing and implementing interprofessional rehabilitation programs in a similar context particularly in low- and middle-income countries.Trial registrationThis trial is registered at clinicaltrials.gov (registration number, NCT05866146, date of registration, 19th July 2023).Supplementary InformationThe online version contains supplementary material available at 10.1186/s40814-026-01866-y.Keywords: Chronic low back pain, Rehabilitation, Interprofessional, Multidisciplinary, Feasibility, Pilot randomized controlled trial Background Chronic low back pain (CLBP) is defined as pain localized below the costal border margin and above the inferior gluteal folds, with or without leg pain lasting longer than 3 months [1–3]. People with CLBP often experience activity limitations, restrictions of participation in work, and poor health-related quality of life [4–8]. In addition, depression and poor social relationships are commonly reported in people with CLBP [9–11]. According to the 2017 Global Burden of Disease estimates, the numbers of people with low back pain (LBP) increased from 377.5 million in 1990 to 577.0 million in 2017. Moreover, CLBP remained the leading cause of years lived with disabilities (YLDs) globally [12]. The Global Burden of Disease studies suggest that YLDs is increasing globally, and that the increase is primarily associated with increasing YLDs associated with musculoskeletal conditions in low- and middle-income countries [12]. While evidence is limited, the studies that have investigated the prevalence of LBP in Ethiopia indicate that LBP is a prevalent problem in Ethiopia. It has been reported that between 48.9 and 76% of the working population experiences LBP [13–18]. Practice guidelines for CLBP recommend interprofessional, biopsychosocial rehabilitation [19, 20]. These recommendations are based on systematic reviews indicating interprofessional rehabilitation programs that include a combination of physical, psychological, behavioral, and/or work-related components are more effective than usual care for improving health-related quality of life, reducing pain, and improving function and workability for people with CLBP [9, 21–25]. Unfortunately, the available evidence is mainly from developed countries and therefore, little is known about the effects or feasibility of interprofessional rehabilitation programs in low- and middle-income countries, including Ethiopia [19, 20], where effective interventions are likely to have the biggest impact on the growing YLD associated with CLBP. Hence, this pilot RCT aims to evaluate the feasibility of conducting a future fully powered randomized control trial (RCT) to evaluate the effectiveness of an interprofessional rehabilitation program compared to the usual care for people with CLBP in Ethiopia. The rehabilitation program was created in alignment with the UK Medical Research Council Guidelines for the development and evaluation of complex interventions [26] using a robust intervention mapping process that included experts in low back pain management, interprofessional rehabilitation programs, and the Ethiopian health system context. This pilot study will be the first of its kind in Ethiopia and it will be crucial to determining the feasibility of conducting a clinical trial in this context and for informing components of the main trial design to address uncertainties and increase the likelihood of successfully conducting the definitive RCT in the future [27–29]. Methods Study design A two-arm parallel open-label pilot randomized control trial (RCT) with a 1:1 allocation to an interprofessional rehabilitation program or usual care will be conducted along with embedded mixed methods process evaluation [26]. The methods process evaluation will allow for an assessment of the extent to which the interprofessional rehabilitation program was implemented as planned and a detailed understanding of the contextual factors, from the perspectives of patients and providers, that may have influenced the implementation process [30, 31]. The reporting in this protocol is consistent with the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) [32] checklist. The Consolidated Standards of Reporting Trials (CONSORT) checklist for reporting randomized pilot or feasibility trials [33] will be followed as a guide to write and report the trial. Study setting The study is carried out at a physiotherapy outpatient clinic in the University of Gondar Specialized Hospital, Ethiopia, from April 2023 to December 2023. Study participants and recruitment procedures This protocol is being published after enrollment, but prior to the last follow-up visit of the participants. Consecutive people with CLBP seeking care in either the outpatient department or physiotherapy clinic at the University of Gondar Specialized Hospital in Ethiopia between April and July 2023 were informed about the study after their healthcare consultation and invited to participate in the trial by a research assistant (a physiotherapist trained on the inclusion and exclusion criteria) [34, 35]. People identified with CLBP by their health professional were further assessed through a focused history and physical examination by the study physiotherapist to determine eligibility. Those meeting the inclusion criteria were invited to share their contact information with a research team member for enrollment. The research team member met with the interested potential participants, confirmed the eligibility criteria were met, and provided and read a letter of information describing the purpose of the study, trial procedures, benefits, and risks. For the qualitative interviews conducted as part of the process evaluation, purposive sampling will be used to recruit a diverse sample of patient participants from the intervention group, reflecting variation in age, sex, duration of CLBP, and adherence to the program. Written informed consent was obtained prior to initial assessment from participants who agree to participate. Ethical clearance is obtained from the Health Sciences Research Ethics Board at Queens University, Canada (REH-871-23), and the Research Ethics Board at University of Gondar, Ethiopia (R/T/T/C/Eng./439/3/2023). Study eligibility criteria Inclusion criteria Adults 18 years of age or older, with chronic low back pain (“pain and discomfort localized below the costal margin and above the inferior gluteal folds, with or without leg pain”) that persists for 3 months or more, were included in this trial [9, 22]. We focused on adults because one of our secondary outcome measures focuses on assessing work ability. Moreover, available evidence indicates that 75% of people with CLBP are adults [36]. Exclusion criteria Patients who have serious known or suspected spinal pathology (e.g., tumors, vertebral fractures, cauda equina syndrome, infections, spinal metastases, and inflammatory diseases), spinal surgery within the last 12 months [37], CLBP due to known specific pathologies (e.g., osteoporosis, rheumatoid arthritis, severe spinal stenosis), or CLBP associated with other known inflammatory articular conditions (e.g., ankylosing spondylitis) were excluded [9, 22]. Sample size We recruited a total of 40 (i.e., 20 interventions and 20 controls) people with CLBP to evaluate the trial’s feasibility and calculate the parameter estimates for the main trial, allowing for an estimated 10% loss to attrition. We determined the sample size by applying the rule of thumb as described by Whitehead et al. [38] and Browne [39], and anticipating medium standardized effect size in the future trial based on the minimal important difference on the Roland-Morris Questionnaire, a primary outcome for the full-scale trial (2.5 points) [40] and a standard deviation of 5.8 points obtained from previous research on interprofessional rehabilitation programs [41]. This rule of thumb suggests recruiting 15 people per arm for an anticipated medium effect size in order to obtain an acceptably precise estimated standard deviation in the pilot trial to use for the sample size calculation for the future trial [39, 42]. Additionally, through collaborative discussions with researchers and knowledge users, this sample was determined to be adequate to confidently assess the primary feasibility outcomes for this pilot trial (recruitment, retention, outcome measure completion, and treatment fidelity). For the qualitative component of the process evaluation, we will invite 10–15 study participant patients from the intervention group that represent the range of diverse subjects (e.g., different age groups, genders, and duration of back pain) using purposive sampling technique. In addition, all healthcare providers who provide the intervention will be interviewed. Treatment allocation and randomization Each participant was allocated/randomized 1:1 to the intervention and control groups. A simple block randomization method using a computer randomization software with random block sizes of 4 to 8 was employed to randomize subjects into the intervention and control groups. All possible combinations with equal numbers for both groups within each block were calculated. Then, we randomly selected block sizes and created a randomization list to determine the patient’s allocation into the intervention and control groups [43, 44] (see Fig. 1). Study flow chart Allocation concealment A research team member not involved in other parts of this study created the randomization sequence and placed each of the allocation assignments in sealed, opaque envelopes to ensure allocation concealment. After baseline assessment, the research assistant who supported the patient to complete the baseline assessment opened the envelope, revealing the treatment allocation and scheduled the patient for the intervention group to which they were assigned. Blinding Blinding of patients and healthcare providers was not possible due to the nature of the interventions being compared [45, 46]. Data will be collected by a research team member who is blinded to the treatment allocation; however, the outcomes assessed will be patient-reported outcome measures and therefore the assessor will also not be blind to the group allocation. Analysis will be conducted by a blinded research team member. Interventions Interprofessional rehabilitation program Participants of the index intervention group received interprofessional rehabilitation program developed for people with CLBP that contained components aimed at enabling optimal physical, psychological, and social functioning, including addressing the work abilities of participants [22, 47]. This interprofessional rehabilitation program was systematically developed using the Intervention Mapping framework [48] and the UK Medical Research Council (MRC) guideline for development and evaluation of complex intervention [26], leveraging the expertise of experts in CLBP, interprofessional rehabilitation, and experienced clinicians with in-depth knowledge of the Ethiopian context. The program is an outpatient program based on a biopsychosocial model [49] and designed to provide comprehensive, interprofessional care for people with CLBP. The program consisted of 12 group sessions and 24 individual sessions, delivered through four visits per week over a 4-week period. In total, participants completed 36 sessions across 16 visits. Each visit, lasting 2 h, included multiple sessions (2 to 3 per visit), such as one group session combined with two individual sessions. Group sessions were conducted with either 6 or 10 individuals, depending on the type of session. Pain education sessions were delivered to groups of 10 participants, while exercise and activity components were provided to groups of 6 participants. The interprofessional rehabilitation program includes multiple treatment components, integrating comprehensive assessment, physical activity and exercises, pain education, cognitive behavioral therapy, ergonomics, and functional task-oriented interventions. Comprehensive assessment and goal setting: Each participant will undergo a comprehensive assessment of physical function, psychological factors, work-related factors, and lifestyle habits, so that patients and care providers together set meaningful, individual, therapeutic goals. Brief introduction and overview of the rehabilitation program will be provided to the participants before the assessment by physiotherapist. Physical activity and exercise interventions: Participants will receive seven group sessions and 16 individual sessions, which included graded stretching and range of motion exercises to improve flexibility and mobility; strengthening and endurance exercises to enhance spinal muscular strength, functional ability, and reduce pain; stability exercises to support core and lumbar spine stability; motor control and sensorimotor training to improve neuromuscular coordination; graded training of muscle strength, coordination, and endurance to improve patients’ ability to perform more challenging body movements with adequate strength, coordination, and endurance; and posture, muscle control and coordination of basic body movements and balance training to enhance postural control and functional stability. These interventions were supervised by physiotherapists, with each session lasting between 30 and 60 min. Pain education: Participants will receive two group and four individual pain education sessions, which included education on the contributors of low back pain using a biopsychosocial model, pain neuroscience education, back school education focusing on basic anatomy, biomechanics of the spine, spinal muscle functions, and ergonomic principles related to spinal positioning, self-management support education, and education on treatment options. The educational module, which included all educational components such as self-management strategies and home-based exercises, was developed in Amharic (local language) and provided to all participants. Education was delivered by physiotherapists, a neurosurgeon, and a clinical psychologist. Psychological interventions: Two group and three individual psychological intervention sessions will incorporate cognitive behavioral therapy (CBT) to help participants recognize and modify maladaptive thoughts, emotions, and behaviors, along with psychoeducational support aimed at enhancing pain coping strategies and reducing fear-avoidance, catastrophizing, and negative appraisals. The psychosocial interventions were delivered by a clinical psychologist. Ergonomic and task-oriented interventions: Participants receive one group and one individual session that included interventions focused on simulated daily activities and work tasks to enhance functional capacity, as well as vocational counseling and ergonomic advice to enhance performance in both work and home settings delivered by occupational therapists and physiotherapists. The interventions will be carried out in the outpatient setting at the physiotherapy department, University of Gondar Specialized Referral Hospital, the same location where participants were recruited. The intervention will be provided by a team of healthcare providers with different professional backgrounds and training. The interprofessional team will consist of experienced one general practitioner (GP), one neurosurgeon, five physiotherapists, one occupational therapist, and one clinical psychologist working at the University of Gondar Specialized Referral Hospital. Healthcare providers will participate in a 2-day training related to the trial procedures and characteristics of the interprofessional rehabilitation program. All healthcare providers have a minimum of 5 years of experience and understand the Ethiopian health system. The treating health professionals from various disciplines and backgrounds are expected to collaborate and work closely with each other and the patients [50–52]. For the purpose of this study, the Canadian Interprofessional Health Collaborative (CIHC) framework [53] will be used to guide the interprofessional collaborative care. With the aim of improving integration and coordination of care among treating interprofessional team members, a shared treatment philosophy aimed at improving physical, social, and psychological functioning, continuous daily communication among on-site healthcare providers, and active patient participation will be emphasized as components of the interprofessional rehabilitation program. Usual care The comparison group participants will receive the usual care according to the current standard practices at University of Gondar Specialized Referral Hospital for over the same 4-week period. The usual care (accepted standard of care) intervention will be monitored but not controlled by the research team in order to accurately reflect usual care at the University of Gondar Hospital. The usual care currently implemented includes mainly pharmacological treatment (pain medication) and back pain advice. The usual care may also include referral to physical therapy, which may include exercise, further education, and manual therapy. Management of CLBP in Ethiopia is predominantly undertaken by physicians. Physicians are the initial point of contact and, following a diagnostic triage, determine the course of treatment and may also refer according to the initial assessment. Physiotherapy is mostly used as a referral service by doctors and psychologists, occupational therapists, and neurosurgeons are not often integrated into patients’ care for CLBP. Participants in both groups will be able to seek extra medical assistance. Ensuring fidelity to intervention and minimizing contamination Fidelity to treatment refers to the degree to which an intervention or program is delivered as intended [54, 55]. To ensure treatment fidelity, the treating health professionals will be trained for 2 days on the intervention protocol and trial procedures. Moreover, healthcare providers and patients will be encouraged to strictly adhere to the intervention protocol. We will also monitor the implementation of the intervention through regular direct observations of sessions, using a structured checklist to assess adherence to the intervention protocol. Protocol deviations and modification Any protocol modification or deviation during the delivery of the intervention will be communicated with the ethics review board, recorded in the trial registry, participants will be updated about the change, and reported in the manuscript of the completed pilot study. Data collection The data will be collected by a trained research assistant who will be blind to the group assignment using interview-administered approach at three time points: at baseline (before the start of the intervention), in week 5 (immediately following the final visit for the intervention), and in the 17th week (12 weeks after intervention completion). Data will be collected in-person at the baseline and 5th week. Follow-up data will be assessed on the 17th week by telephone. For the qualitative interviews as part of the mixed methods process evaluation, the principal investigator will conduct face-to-face, in-depth semi-structured interviews to explore the acceptability of the intervention and trial procedures from the perspectives of both treating health professionals and study participants’ perspectives. The interview will be conducted in Amharic, the local language. The interview will focus on exploring study participants’ and healthcare providers’ overall experience during the intervention, perceived benefits and drawbacks of the intervention, satisfaction with the intervention, and acceptability of the intervention. Moreover, the interviews will explore contextual factors influencing implementation of the new interprofessional rehabilitation program, including barriers and facilitators to implementation. The interview will be conducted soon after the completion of the intervention. The embedded qualitative interviews will be conducted using a qualitative description approach [56]. Adverse events and other unintended effects of the intervention will be collected and reported. Please see Table 1: schedules of enrollment and assessments. Table 1Schedule of enrolment, interventions, and assessments Schedule of enrolment, interventions, and assessments Outcomes Sociodemographic information The following sociodemographic and behavioral characteristics will be collected at baseline: age, gender, highest level of education completed, marital status, physical activity level, duration of back pain, medication use, and comorbidities. Outcome measures Trial feasibility outcomes (primary outcomes) I.Recruitment rateRecruitment rate will be calculated as the number of patients recruited per week. This will be calculated as 40 participants (target sample size) divided by the number of weeks it takes to recruit the targeted sample [57]. Progression criteria were established a priori to determine whether progression to a future fully powered randomized controlled trial would be feasible. Recruitment feasibility will be considered acceptable if at least three participants are recruited per week [58]. We will also record the number of patients screened, the number of eligible patients invited to participate, and the number of eligible patients who declined to consent to participate in the study. We will record the reason for their declining when provided. Recruitment rate Recruitment rate will be calculated as the number of patients recruited per week. This will be calculated as 40 participants (target sample size) divided by the number of weeks it takes to recruit the targeted sample [57]. Progression criteria were established a priori to determine whether progression to a future fully powered randomized controlled trial would be feasible. Recruitment feasibility will be considered acceptable if at least three participants are recruited per week [58]. We will also record the number of patients screened, the number of eligible patients invited to participate, and the number of eligible patients who declined to consent to participate in the study. We will record the reason for their declining when provided. II.Retention rateThe retention rate will be calculated as the percentage of participants that complete assessments at each follow-up point out of the total number of participants that consent to participate. Participant retention will be considered feasible if at least 80% of participants complete outcome assessments at both the 5-week assessment and the 12-week follow-up, based on evidence suggesting that attrition greater than 20% may compromise trial validity [59, 60]. Retention rate The retention rate will be calculated as the percentage of participants that complete assessments at each follow-up point out of the total number of participants that consent to participate. Participant retention will be considered feasible if at least 80% of participants complete outcome assessments at both the 5-week assessment and the 12-week follow-up, based on evidence suggesting that attrition greater than 20% may compromise trial validity [59, 60]. III.Feasibility of data collection procedures and outcome measure completion rateOutcome measure completion rate will be calculated at each time point, using the number of completed items across all outcome measures out of the total number of items asked to participants. Completion of outcome measures will be considered acceptable if more than 90% of data are completed among retained participants [61]. We will also document the time taken to complete the data and a duration of completion of <45 min for each assessment will be determined feasible, based on input from our clinical partners. Feasibility of data collection procedures and outcome measure completion rate Outcome measure completion rate will be calculated at each time point, using the number of completed items across all outcome measures out of the total number of items asked to participants. Completion of outcome measures will be considered acceptable if more than 90% of data are completed among retained participants [61]. We will also document the time taken to complete the data and a duration of completion of <45 min for each assessment will be determined feasible, based on input from our clinical partners. Outcome measures planned for the full trial (secondary outcomes) Outcome measures planned for the fully powered trial will be collected and reported descriptively. IV.Physical functioning (primary outcome for the future fully powered trial)The cross-culturally adapted Amharic version of the Roland-Morris Disability Questionnaire (RMDQ) [62] will be used to measure the physical functioning of patients with CLBP. The RMDQ is the most recommended and used instrument to measure LBP patients’ physical functioning [63, 64]. It demonstrates excellent reliability and validity for the assessment of back pain-related disability in persons with CLBP [65]. The RMDQ consists of 24 items assessing physical functions that are likely to be affected by LBP; each item is marked if it applies to the patient that day. Each item is given a score of either a 1 (yes) or 0 (no) [64, 66]. The total number of marked statements provides a score of 0 to 24 [67]. Physical functioning (primary outcome for the future fully powered trial) The cross-culturally adapted Amharic version of the Roland-Morris Disability Questionnaire (RMDQ) [62] will be used to measure the physical functioning of patients with CLBP. The RMDQ is the most recommended and used instrument to measure LBP patients’ physical functioning [63, 64]. It demonstrates excellent reliability and validity for the assessment of back pain-related disability in persons with CLBP [65]. The RMDQ consists of 24 items assessing physical functions that are likely to be affected by LBP; each item is marked if it applies to the patient that day. Each item is given a score of either a 1 (yes) or 0 (no) [64, 66]. The total number of marked statements provides a score of 0 to 24 [67]. V.Pain intensityPain intensity will be measured using the pain severity items from the Amharic version of the Brief Pain Inventory—Short Form (BPI-sf) questionnaire. The questionnaire demonstrated validity in the assessment of pain severity among people with LBP [68]. Moreover, the Amharic version of the questionnaire has demonstrated reliability and validity among people with chronic musculoskeletal pain in Ethiopia [50, 69]. The Brief Pain Inventory—Short Form (BPI-sf) severity items ask patients to rate their worst, least, average, and current pain intensity on a scale of 0 to 10. The mean of the four ratings is calculated as their pain severity index [51]. Pain intensity Pain intensity will be measured using the pain severity items from the Amharic version of the Brief Pain Inventory—Short Form (BPI-sf) questionnaire. The questionnaire demonstrated validity in the assessment of pain severity among people with LBP [68]. Moreover, the Amharic version of the questionnaire has demonstrated reliability and validity among people with chronic musculoskeletal pain in Ethiopia [50, 69]. The Brief Pain Inventory—Short Form (BPI-sf) severity items ask patients to rate their worst, least, average, and current pain intensity on a scale of 0 to 10. The mean of the four ratings is calculated as their pain severity index [51]. VI.Health-related quality of life (HRQoL)HRQoL will be measured using the 36-item short-form health survey (SF-36) questionnaire. In groups of patients with low back pain, the SF-36’s reliability and construct validity have been well established [52, 70]. The SF-36 is classified into two different health constructs: the physical component summary score (PCS) and the mental component summary score (MCS) [71]. The SF-36 has subscales that assess general health, physical functioning, bodily pain, mental health, role functioning, emotional functioning, vitality, and social functioning, among other things [70, 71]. Health-related quality of life (HRQoL) HRQoL will be measured using the 36-item short-form health survey (SF-36) questionnaire. In groups of patients with low back pain, the SF-36’s reliability and construct validity have been well established [52, 70]. The SF-36 is classified into two different health constructs: the physical component summary score (PCS) and the mental component summary score (MCS) [71]. The SF-36 has subscales that assess general health, physical functioning, bodily pain, mental health, role functioning, emotional functioning, vitality, and social functioning, among other things [70, 71]. VII.Depression/anxietyWe will use the Hospital Anxiety and Depression Scale (HADS) to measure depression/anxiety because it was developed for a general population. It is widely used in clinical trials [72, 73]. It includes 14 questions providing separate scores for depression and anxiety [73]; the two-factor structure is consistent across diverse clinical samples [74]. It has demonstrated internal consistency, construct validity, and responsiveness [75]. Depression/anxiety We will use the Hospital Anxiety and Depression Scale (HADS) to measure depression/anxiety because it was developed for a general population. It is widely used in clinical trials [72, 73]. It includes 14 questions providing separate scores for depression and anxiety [73]; the two-factor structure is consistent across diverse clinical samples [74]. It has demonstrated internal consistency, construct validity, and responsiveness [75]. VIII.Self-efficacyTo measure self-efficacy of patients with CLBP, we will utilize the Amharic version Pain Self-Efficacy Questionnaire (PSEQ-Am) cross-culturally translated and adapted for people with LBP in Ethiopia by Chala et al. [76]. The questionnaire has been reported as a reliable and valid tool for use in research and clinical practice in the Ethiopian setting among LBP population [76]. The Pain Self-Efficacy Questionnaire (PSEQ) is a 10-item survey designed to determine how confident people with chronic pain are in their ability to complete their usual daily activities despite the pain. It examines self-efficacy in a variety of areas, including home duties, socializing, working, and managing with pain without medicine [77]. The PSEQ asks patients to assess their level of confidence on a scale of 0 (not at all confident) to 6 (very confident) (completely confident). Total scores are derived by summing the individual items’ values, which range from 0 (low self-efficacy) to 60 (high self-efficacy) (more self-efficacy). Self-efficacy To measure self-efficacy of patients with CLBP, we will utilize the Amharic version Pain Self-Efficacy Questionnaire (PSEQ-Am) cross-culturally translated and adapted for people with LBP in Ethiopia by Chala et al. [76]. The questionnaire has been reported as a reliable and valid tool for use in research and clinical practice in the Ethiopian setting among LBP population [76]. The Pain Self-Efficacy Questionnaire (PSEQ) is a 10-item survey designed to determine how confident people with chronic pain are in their ability to complete their usual daily activities despite the pain. It examines self-efficacy in a variety of areas, including home duties, socializing, working, and managing with pain without medicine [77]. The PSEQ asks patients to assess their level of confidence on a scale of 0 (not at all confident) to 6 (very confident) (completely confident). Total scores are derived by summing the individual items’ values, which range from 0 (low self-efficacy) to 60 (high self-efficacy) (more self-efficacy). IX.Global rating of changeTo measure global rating of change, we will use an 11-point global rating of change scale (GROC) (−5 to +5), ranging from −5 (very much worse), through 0 (unchanged) to +5 (completely recovered). The global rating of change (GRC) scales are used to assess self-perceived improvement/changes in health [78]. Global rating of change To measure global rating of change, we will use an 11-point global rating of change scale (GROC) (−5 to +5), ranging from −5 (very much worse), through 0 (unchanged) to +5 (completely recovered). The global rating of change (GRC) scales are used to assess self-perceived improvement/changes in health [78]. Process evaluation I.Intervention fidelityThe modified conceptual framework for evaluation of implementation fidelity developed by Hasson [79] will be used as a framework to evaluate the intervention implementation process and its fidelity. Within this model, fidelity is defined as adherence to the planned intervention and four components of fidelity are identified: (i) content (whether each of the intervention components was delivered as planned), (ii) coverage (the proportion of the target group who participated in the intervention), (iii) frequency, and (iv) duration (whether the intervention components were implemented as often and for as long as planned). Furthermore, the following potential moderators of implementation fidelity will be explored: participant responsiveness (dose received, satisfaction, acceptability, and perceived relevance and value of the intervention), intervention complexity, comprehensiveness of intervention description, strategies to facilitate implementation (training, reminders, supports for delivery), quality of delivery, recruitment (how were people identified for the intervention and how was engagement maintained), and context (political-, organizational-, team-, provider-, and patient-level factors influencing implementation).Fidelity rate will be calculated for each intervention session. Intervention fidelity will be considered acceptable to proceed with the fully powered trial if at least 75% of the planned intervention components are delivered during each treatment session [80].To evaluate the treatment fidelity, observations of the intervention process (e.g., the intervention delivery sessions, duration, and contents), field notes taken during observations, an attendance list from each intended session, a treatment fidelity checklist completed by providers, documentation of any protocol deviations, interviews with providers involved in delivery of the intervention, and interviews of patients participating in the intervention will be used (Table 2). Intervention fidelity The modified conceptual framework for evaluation of implementation fidelity developed by Hasson [79] will be used as a framework to evaluate the intervention implementation process and its fidelity. Within this model, fidelity is defined as adherence to the planned intervention and four components of fidelity are identified: (i) content (whether each of the intervention components was delivered as planned), (ii) coverage (the proportion of the target group who participated in the intervention), (iii) frequency, and (iv) duration (whether the intervention components were implemented as often and for as long as planned). Furthermore, the following potential moderators of implementation fidelity will be explored: participant responsiveness (dose received, satisfaction, acceptability, and perceived relevance and value of the intervention), intervention complexity, comprehensiveness of intervention description, strategies to facilitate implementation (training, reminders, supports for delivery), quality of delivery, recruitment (how were people identified for the intervention and how was engagement maintained), and context (political-, organizational-, team-, provider-, and patient-level factors influencing implementation). Fidelity rate will be calculated for each intervention session. Intervention fidelity will be considered acceptable to proceed with the fully powered trial if at least 75% of the planned intervention components are delivered during each treatment session [80]. To evaluate the treatment fidelity, observations of the intervention process (e.g., the intervention delivery sessions, duration, and contents), field notes taken during observations, an attendance list from each intended session, a treatment fidelity checklist completed by providers, documentation of any protocol deviations, interviews with providers involved in delivery of the intervention, and interviews of patients participating in the intervention will be used (Table 2). II.Intervention adherenceAn adherence checklist will be used to assess adherence. After each session, the care provider and patient will collaboratively fill out the adherence checklist to identify the intervention activities completed, partially completed, or not completed [81].Adherence rates will be calculated for each intervention component. Adherence to intervention components will be categorized as good (≥75%), moderate (50–75%), or low (<50%) according to the proportion of participants adhering to each intervention component [80]. Intervention adherence An adherence checklist will be used to assess adherence. After each session, the care provider and patient will collaboratively fill out the adherence checklist to identify the intervention activities completed, partially completed, or not completed [81]. Adherence rates will be calculated for each intervention component. Adherence to intervention components will be categorized as good (≥75%), moderate (50–75%), or low (<50%) according to the proportion of participants adhering to each intervention component [80]. III.Intervention acceptability and contextual factor influencing implementationA qualitative description approach [82] will be used to evaluate the implementation of the intervention, including exploring patients’ and healthcare providers’ experiences, perspectives on trial procedures, and feasibility of implementing the intervention with fidelity. The qualitative component of this research involves qualitative interviews using a semi-structured interview guide; we will explore experiences and perspectives on implementation of the new interprofessional rehabilitation program, the context of implementation, as well as barriers and facilitators to implementation from the perspectives of both healthcare providers who deliver the intervention and patient participants. The in-depth qualitative interviews will be embedded/conducted immediately after completion of the intervention period (Table 3). Intervention acceptability and contextual factor influencing implementation A qualitative description approach [82] will be used to evaluate the implementation of the intervention, including exploring patients’ and healthcare providers’ experiences, perspectives on trial procedures, and feasibility of implementing the intervention with fidelity. The qualitative component of this research involves qualitative interviews using a semi-structured interview guide; we will explore experiences and perspectives on implementation of the new interprofessional rehabilitation program, the context of implementation, as well as barriers and facilitators to implementation from the perspectives of both healthcare providers who deliver the intervention and patient participants. The in-depth qualitative interviews will be embedded/conducted immediately after completion of the intervention period (Table 3). Table 2Implementation fidelity for each intervention component and assessment methodsTreatment fidelity componentsApproaches to fidelity assessmentTiming/extent to which these are conductedFidelity of delivery (adherence to the protocol) Content• Whether each of the intervention components was delivered as plannedObservations of the intervention delivery sessions, field notes taken during observations, and a treatment fidelity checklist completed by providersThroughout the intervention period Quality of deliveryObservations of the intervention delivery sessionsSelected intervention delivery sessions Frequency/duration• Whether the intervention components were implemented as often and for as long as plannedA treatment fidelity checklist completed by providersThroughout the intervention periodFidelity of receipt Coverage• The proportion of the target group who participated in the interventionAn attendance list from each intended session and monitor participant enactment fidelityThroughout the intervention period Participant engagement• Understood/can use intervention componentsObservations of the intervention process (e.g., delivery, receipt, enactment) and post-intervention interviewsThroughout the intervention process and post-intervention Duration• Intervention sessions completed duration of intervention sessionsAn attendance list from each intended session and a treatment fidelity checklist completed by providersThroughout the intervention processParticipant responsiveness Participant responsiveness• Dose received, satisfaction, and perceived relevance and value of the interventionObservations of the intervention process and post-intervention interviews with healthcare providers and patients participating in the interventionPost-intervention Acceptability of intervention and trial proceduresPost-intervention interview with healthcare providers and patients participating in the intervention, observations, research team meeting note, and field notes (e.g., documenting their engagement, understanding of the procedures)Throughout the intervention process and post-interventionOutcomes Care providers’ and patients’ experience/performancePost-intervention interviews with healthcare providers and patients participating in the interventionPost-intervention Implementation fidelity for each intervention component and assessment methods Content • Whether each of the intervention components was delivered as planned Frequency/duration • Whether the intervention components were implemented as often and for as long as planned Coverage • The proportion of the target group who participated in the intervention Participant engagement • Understood/can use intervention components Duration • Intervention sessions completed duration of intervention sessions Participant responsiveness • Dose received, satisfaction, and perceived relevance and value of the intervention Table 3Measures, assessment, and measurement occasionsOutcome measuresBaseline survey5th week (soon after the intervention delivery)17th week (12-week follow-up)Primary outcomes Recruitment rate✔ Retention rate✔✔ Outcome measure completion rate✔✔✔Secondary outcome measures Physical functioning✔✔✔ Pain intensity✔✔✔ HRQoL✔✔✔ Psychological functioning✔✔ Self-efficacy✔✔ Global rate of change✔ Patient satisfaction✔ Sociodemographic and behavioral data✔Process evaluation Intervention fidelity✔ Intervention adherence✔ Barriers and facilitators of intervention delivery and receipt✔ Measures, assessment, and measurement occasions Data management and analysis The quantitative data will be coded and entered into Epi Info version 7 statistical package by two data clerks. The analysis will be completed using STATA version 18. The PI will then confirm and double-check the entered data for any possible errors by checking 10% of entered data with the original paper copies of data collected. Descriptive statistics will be used to summarize the data on participant sociodemographic information. Mean and standard deviation will be calculated and reported for normally distributed, continuous data. Medians and interquartile range will be calculated and reported for non-normal data. Frequencies and proportions will be calculated and reported for categorical data. The primary feasibility outcomes, including recruitment rates, retention rate, adherence rate, and completion of the questionnaire, will be analyzed and reported descriptively. Hence, we will compute frequencies, mean, median, standard deviation, interquartile range, rates, and 95% confidence intervals when appropriate. We will calculate and report the group mean difference, standard deviation, change score, and treatment effects for the outcome measures with a 95% confidence interval for all outcome measures planned for the full trial. Although evaluating between group differences is not the aim of this pilot study, we will estimate the preliminary effect of the intervention on clinical outcomes using linear mixed effects modeling with repeated measures in order to inform sample size calculations for the full trial. We will estimate mean differences between groups along with 95% confidence intervals at each time point (i.e., pre-test, post-test, and follow-up). The pilot analysis will be performed according to the intention-to-treat (ITT) principle. Regardless of adherence to the study protocol, all patients will be assessed in the ITT analysis according to their first allocated trial arm at baseline. Patients’ characteristics will be compared between those who were lost to follow-up and those who were included to determine whether data was likely to be missing at random [83]. We will handle missing data using multiple imputation (MI). For the qualitative data, the interview will be audio-recorded and first transcribed verbatim in the original Amharic language. Transcripts will be loaded into NVivo V12 for investigators to perform the coding and content analysis. A qualitative content analysis approach as described by Elo and Kyngäs [84] will be followed to analyze the qualitative data in a qualitative description tradition. The analysis will be performed in three phases: (i) preparation phase, where initially the panel members comment read and re-read to be immersed in the data and obtaining the sense of data, (ii) organizing phase, in which open coding, grouping, creating categories, and abstracting will be performed, and (iii) reporting the analyses results. The principal investigator (PI) will conduct the analysis, ensuring rigor and trustworthiness through reflexivity, member checking with the research team, prolonged engagement with the data, maintaining an audit trail of the research process, and independent scrutiny. Discussion CLBP remains a significant public health problem in developed and developing countries, including African nations [85–88]. In recent years, there has been growing interest in implementing evidence-based interprofessional CLBP interventions in developing countries to address the growing burden of LBP-related disability [9, 89, 90]. Studies on the effectiveness of interprofessional rehabilitation program for people with CLBP in LMIC have the greatest potential for impact, but it is unclear whether it is feasible to test interventions in these settings. Before completing a definitive evaluation, it is also recommended to test new interventions in a pilot trial to investigate key uncertainties in the design and to assess the feasibility of conducting the future definitive RCT [26, 91, 92]. Therefore, this pilot RCT aims to evaluate the feasibility of conducting a future definitive RCT to assess the effectiveness of an interprofessional rehabilitation program compared to the usual care for patients with CLBP in Ethiopia. This will provide the first estimates of the feasibility of carrying out such work. In addition, this pilot RCT can assist us in determining an intervention’s acceptability from the standpoint of multiple relevant groups, including patients, intervention providers, and health professionals [93]. The intervention is the first of its kind in the Ethiopian setting and this will be the first pilot RCT to assess the feasibility of conducting an RCT on the effectiveness of interprofessional rehabilitation on health outcomes for people with CLBP in the continent of Africa [94]. The results of this pilot research are expected to inform a future trial that provides definitive evidence on the impact of an interprofessional rehabilitation program for CLBP in the low-resource settings. Moreover, it addresses the key uncertainties recognized in the development work and feasibility of proceeding to the future definitive RCT [33, 91, 95]. Furthermore, this pilot RCT provides a more realistic analysis of recruitment rate, loss to follow-up, randomization process, intervention implementation, blinded assessment techniques, and blinded intervention retention [29], crucial feasibility information for future full effectiveness trial in a low-resource setting. The embedded process evaluation may provide valuable evidence for health system decision-makers and health care teams on the factors influencing implementation and effectiveness of the intervention. Furthermore, the results of this study may create essential conditions for evidence-based practice among healthcare professionals and offer invaluable insights into the implementation of interprofessional rehabilitation for patients with CLBP in Ethiopia. Moreover, this study will provide insights into healthcare providers’ perspectives regarding the upcoming intervention implementation and help them be familiar with the program. It may also help develop a deep understanding of implementation strategies for the new intervention. In addition, if this feasibility trial is successful, the data will serve as the foundation for a large definitive clinical trial. It has a significant impact on participants at risk of substantial limitations in their physical, mental, and social functioning due to CLBP, helping them achieve an independent and meaningful life. This study will also help policymakers develop best practice clinical guidelines/policies for CLBP rehabilitation in Ethiopia. The findings of this study will also provide baseline information for researchers and health care professionals about the feasibility of conducting full RCT on interprofessional rehabilitation trials, process evaluation, and cost-effectiveness of the intervention. Also, help design and implement interprofessional rehabilitation for chronic low back pain. Moreover, the findings of this study will help patients with chronic low back pain to receive quality of care and have significantly better health outcomes. However, this pilot RCT is not without limitations. One of the main limitations of our study is its single-site design, which limits the generalizability of our findings. Since patients were recruited from one hospital in Ethiopia, the results may not fully reflect the experiences of healthcare professionals or patients in other LMICs. Some intervention components or challenges identified may not be applicable across diverse LMIC healthcare settings. Our findings are most relevant to healthcare delivery systems similar to that of the University of Gondar Specialized Hospital in Ethiopia. To enhance the applicability of our results, we recommend conducting a multi-site, large-scale trial in the future. In addition, while the trained research assistant will collect data and remain blinded to the treatment allocation during the interview-administered data collection, we recognize that blinding will not be fully maintained for patient-reported outcomes. This pilot trial, in general, may serve as an excellent starting point for conducting feasible, scientifically sound, large-scale RCTs to evaluate the effectiveness of interprofessional rehabilitation program for people with CLBP that provide high-quality evidence for practice in the LMIC context. Further research will be needed to explore cost-effectiveness, scalability, and adaptation to different healthcare settings. Additionally, future studies should focus on optimizing the intervention to balance effectiveness with practicality, ensuring its feasibility within resource-constrained environments. Supplementary Information Additional file 1. Appendix 1. Sample information sheet and consent form Additional file 2. Appendix 2. SPIRIT checklist Additional file 3. Appendix 3. CONSORT extension for Pilot and Feasibility Trials Checklist Acknowledgements The authors acknowledge the MasterCard Foundation Scholars Program for funding. Authors’ contributions SDW and JM: contributed to the study design and manuscript write-up. CD, KAG, and EA: contributed to the manuscript write-up and review. All authors read and approved the final version of the manuscript. Funding The MasterCard Foundation Scholarship Program financially supported this research work. The funder had no role in the design of this study, article searching, study selection, reporting of results, and decision to submit for publication. Data availability Not applicable. Declarations Ethics approval and consent to participate Ethical clearance is obtained from the Health Sciences Research Ethics Board at Queens University, Canada (REH-871-23), and the Research Ethics Board at University of Gondar, Ethiopia (R/T/T/C/Eng./439/3/2023). All participants will be assigned an identifier number and treated anonymously in all analyses. Papers and electronic documentation with names and personal identification numbers will be stored securely in locked cabinets or on a password-protected computer. The data will be accessed by the primary investigator, research team, and research assistants/transcribers who are located either in Ethiopia or Canada and who have signed a confidentiality agreement. Consent for publication Not applicable. Competing interests The authors declare that they have no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Additional file 1. Appendix 1. Sample information sheet and consent form Additional file 2. Appendix 2. SPIRIT checklist Additional file 3. Appendix 3. CONSORT extension for Pilot and Feasibility Trials Checklist Data Availability Statement Not applicable.